Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

FDA Gives Nod To BioSante's Estrogen Drug In Hot Flashes

Dec. 19, 2006

By Aaron Lorenzo

FDA Weighing Expanded Use, Sales Of Experimental Drugs

Dec. 18, 2006

By Aaron Lorenzo

Affymax Completes $92M IPO; Funds Planned For EPO Drug

Dec. 18, 2006

By Aaron Lorenzo

FDA Weighing Expanded Use, Sales Of Experimental Drugs

Dec. 18, 2006

By Aaron Lorenzo

Affymax Completes $92M IPO; Funds Planned For EPO Drug

Dec. 18, 2006

By Aaron Lorenzo

GTx Raises $61M To Progress Late-Stage Drug Development

Dec. 15, 2006

By Aaron Lorenzo

GTx Raises $61M To Progress Late-Stage Drug Development

Dec. 15, 2006

By Aaron Lorenzo

Pain's Oxytrex Study Recruiting Highly Dependent Opioid Users

Dec. 14, 2006

By Aaron Lorenzo

Pain's Oxytrex Study Recruiting Highly Dependent Opioid Users

Dec. 14, 2006

By Aaron Lorenzo

Indevus To Pay $120M For Valera In Specialty Buyout

Dec. 13, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...